Budget Express 2026

co-presented by

ASSOCIATE SPONSORS

Parallel Income Plan 2026

Parallel Income Plan 2026

you are here: HomeNewsBusinessStocksSee Dr Reddy's FY12 EPS around Rs 80: Anand Rathi

SHOW NAMES

Trending Topics

business

See Dr Reddy's FY12 EPS around Rs 80: Anand Rathi

Number 2 drugmaker Dr Reddy's Laboratories Ltd said a US district court has cleared the sale of its generic version of Sanofi-Aventis' allergy treatment drug Allegra D24. Sriram Rathi, Anand Rathi Financial Services says it is definitely a positive news for Dr Reddy’s.

first published: Jan 31, 2011 12:54 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347